SixtSKrankenbergHMöhrleC. Endovascular treatment for extensive
aortoiliac artery reconstruction: a single-center experience based on 1712
interventions. J Endovasc Ther.
2013;20:64–73.
2.
SixtSAlawiedAKRastanA. Acute and long-term outcome of
endovascular therapy for aortoiliac occlusive lesions stratified according
to the TASC classification: a single-center experience.
J Endovasc Ther.
2008;15:408–416.
3.
NorgrenLHiattWRDormandyJA. Inter-Society Consensus for the
Management of Peripheral Arterial Disease (TASC II).
J Vasc Surg. 2007;45Suppl S: S5–67.
4.
JongkindVAkkersdijkGJYeungKK. A systematic review of endovascular
treatment of extensive aortoiliac occlusive disease.
J Vasc Surg.
2010;52:1376–83.
5.
KoizumiAKumakuraHKanaiH. Ten-year patency and factors causing
restenosis after endovascular treatment of iliac artery
lesions. Circ J.
2009;73:860–866.
6.
IchihashiSHigashiuraWItohH. Long-term outcomes for systematic
primary stent placement in complex iliac artery occlusive disease classified
according to Trans-Atlantic Inter-Society Consensus
(TASC)-II. J Vasc Surg.
2011;53:992–999.
7.
PulliRDorigoWFargionA. Early and long-term comparison of
endovascular treatment of iliac artery occlusions and
stenosis. J Vasc Surg.
2011;53:92–98.
8.
de
VriesSOHuninkMG.
Results of aortic bifurcation grafts for aortoiliac occlusive
disease: a meta-analysis. J Vasc Surg.
1997;26:558–569.
9.
KashyapVSPavkovMLBenaJF. The management of severe aortoiliac
occlusive disease: endovascular therapy rivals open
reconstruction. J Vasc Surg.
2008;48:1451–1457.
10.
SachwaniGRHansSSKhouryMD. Long-term results of iliac stenting
and aortofemoral grafting for iliac artery occlusions.
J Vasc Surg. 2012 Nov 21 [Epub ahead of
print].
11.
DosluogluHHLallPHarrisLM. Long-term durability of endovascular
and open revascularization for disabling claudication.
J Vasc Surg.
2012;56:1478–1479.
KimYWLeeJHKimHG. Factors affecting the long-term
patency of crossover femorofemoral bypass graft. Eur
J Vasc Endovasc Surg.
2005;30:376–380.
14.
MiiSEguchiDTakenakaT. Role of femorofemoral crossover
bypass grafting for unilateral iliac atherosclerotic disease: a comparative
evaluation with anatomic bypass. Surg
Today.
2005;35:453–458.
15.
PassmanMATaylorLMMonetaGL. Comparison of axillofemoral and
aortofemoral bypass for aortoiliac occlusive disease.
J Vasc Surg.
1996;23:263–271.
16.
El-MassrySSaadESauvageLR. Axillofemoral bypass with externally
supported, knitted Dacron grafts: a follow-up through twelve
years. J Vasc Surg.
1993;17:107–115.
17.
AngleNDorafsharAHFarooqMM. The evolution of the axillofemoral
bypass over two decades. Ann Vasc Surg.
2002;16:742–745.
18.
HertzerNRBenaJFKarafaMT.
A personal experience with direct reconstruction and
extraanatomic bypass for aortoiliofemoral occlusive disease.
J Vasc Surg.
2007;45:527–535.
19.
ReedABConteMSDonaldsonMC. The impact of patient age and aortic
size on the results of aortobifemoral bypass grafting.
J Vasc Surg.
2003;37:1219–1225.
20.
BaumannFRuchMWillenbergT. Endovascular treatment of common
femoral artery obstructions. J Vasc Surg.
2011;53:1000–1006.
21.
ChangRWGoodneyPPBaekJH. Long-term results of combined common
femoral endarterectomy and iliac stenting/stent grafting for occlusive
disease. J Vasc Surg.
2008;48:362–367.
22.
PiazzaMRicottaJJBowerTC. Iliac artery stenting combined with
open femoral endarterectomy is as effective as open surgical reconstruction
for severe iliac and common femoral occlusive disease.
J Vasc Surg.
2011;54:402–411.
23.
DosluogluHHLallPCherrGS. Role of simple and complex hybrid
revascularization procedures for symptomatic lower extremity occlusive
disease. J Vasc Surg.
2010;51:1425–1435.
24.
JacobsDLMotaganahalliRLCoxDE. True lumen re-entry devices
facilitate subintimal angioplasty and stenting of total chronic occlusions:
initial report. J Vasc Surg.
2006;43:1291–1296.
KleinWMvan der GraafYSeegersJ. Long-term cardiovascular morbidity,
mortality, and reintervention after endovascular treatment in patients with
iliac artery disease: the Dutch Iliac Stent Trial study.
Radiology.
2004;232:491–498.
27.
YeWLiuCWRiccoJB. Early and late outcomes of
percutaneous treatment of TransAtlantic Inter-Society Consensus class C and
D aortoiliac lesions. J Vasc Surg.
2011;53:1728–1737.
28.
BosiersMIyerVDelooseK. Flemish experience using the Advanta
V12 stent-graft for the treatment of iliac artery occlusive
disease. J Cardiovasc Surg (Torino).
2007;48:7–12.
29.
MwipatayiBPThomasSWongJ. Covered Versus Balloon Expandable
Stent Trial (COBEST) Co-investigators. A comparison of covered vs bare
expandable stents for the treatment of aortoiliac occlusive
disease. J Vasc Surg.
2011;54:1561–1570.
30.
BekkenJAVosJAAartsRA. DISCOVER: Dutch Iliac Stent trial:
COVERed balloon-expandable versus uncovered balloon-expandable stents in the
common iliac artery: study protocol for a randomized controlled
trial. Trials.
2012;13:215.
31.
RutherfordRBBakerJDErnstC. Recommended standards for reports
dealing with lower extremity ischemia: revised version.
J Vasc Surg.
1997;26:517–538.
32.
VallabhaneniRSorialEEJordanWD. Iliac artery recanalization of
chronic occlusions to facilitate endovascular aneurysm
repairJ Vasc Surg.
2012;56:1549–1554.
